RGEN Repligen Corporation

NAS · US · Healthcare · Medical Instruments & Supplies · repligen.com

189.50USD+4.29%Mkt Cap: 10.69B $P/E: 259.591d ago

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fib…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Bausch + Lomb Corporation

$6.13BUSD

Key Statistics

Company

Market Cap10.69B USD

Enterprise Value10.13B USD

Revenue (TTM)785.10M USD

Gross Profit386.25M USD

Net Income (TTM)48.89M USD

Revenue/Share13.94 USD

Last Price189.50 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees2.0K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)259.59

P/E (Forward)68.58

PEG1.81

EV/EBITDA70.33

EV/Revenue12.91

P/S13.06

P/B4.85

EPS (TTM)0.73

EPS (Forward)2.65

52W Range

100.9990% of range198.86

52W High198.86 USD

52W Low100.99 USD

Profitability

Gross Margin52.32%

Oper. Margin9.31%

EBITDA Margin18.35%

Profit Margin6.62%

ROE2.32%

ROA1.66%

Growth

Revenue Growth11.90%

Earnings Growth-65.90%

Cash Flow & Leverage

Operating CF117.42M USD

CapEx (TTM)25.73M USD

FCF Margin14.45%

FCF Yield1.06%

Net Debt-119.51M USD

Net Debt/EBITDA-0.83

Balance Sheet

Debt/Equity0.33

Current Ratio9.05

Quick Ratio7.30

Book Value/Sh37.43 USD

Cash/Share14.36 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)189.70 USD

Upside (mean)+0.1%

Target Range145.00 USD – 225.00 USD

145.00+0.1% to mean225.00

# Analysts20

Ownership

Shares Out.56.44M

Float53.47M

Insiders5.24%

Institutions119.47%

Short Interest

Short Ratio6.8d

Short % Float11.93%

Short % Out.11.89%

Shares Short6.71M

Short (prev mo.)6.09M

Technical

SMA 50169.67 (+11.7%)

SMA 200143.51 (+32.0%)

Beta1.05

S&P 52W Chg14.58%

Avg Vol (30d)1.10M

Avg Vol (10d)1.29M

Technical Indicators

RSI (14)60.9

MACD6.5379

MACD Signal6.8683

MACD Hist.-0.3305

BB Upper200.24 USD

BB Middle178.62 USD

BB Lower156.99 USD

BB Width24.21%

ATR (14)8.158 USD

Vol Ratio (20d)1.25x